These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7049508)

  • 1. Dependence of renal vasodilator effect of captopril on prevailing plasma renin level in the dog: influence of DOCA-salt treatment.
    Wong PC; Zimmerman BG
    Clin Sci (Lond); 1982 Oct; 63(4):355-60. PubMed ID: 7049508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril.
    Wong PC; Zimmerman BG; Kraft E; Kounenis G; Friedman P
    J Pharmacol Exp Ther; 1981 Dec; 219(3):646-50. PubMed ID: 7028950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of role of sympathetic and renin-angiotensin systems in Goldblatt hypertension with urapidil and captopril.
    Zimmerman BG
    J Hypertens; 1984 Oct; 2(5):485-91. PubMed ID: 6397539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of infused captopril on blood pressure and the renin-angiotensin-aldosterone system in normal dogs subjected to varying sodium balance.
    Morton JJ; Tree M; Casals-Stenzel J
    Am J Cardiol; 1982 Apr; 49(6):1395-400. PubMed ID: 7041583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of renal vasodilation with captopril: saralasin prevents the response in the DOCA-treated, salt-loaded rabbit.
    Hollenberg NK; Passan DR
    Life Sci; 1982 Jul; 31(4):329-34. PubMed ID: 6755124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
    Zimmerman BG; Goering JL; Raich PC
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of captopril, a converting enzyme inhibitor on renal vascular resistance in pentobarbital anesthetized dogs.
    Satoh S; Fujisawa S; Tanaka R; Nakai K
    Jpn J Pharmacol; 1980 Aug; 30(4):515-9. PubMed ID: 7009942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of DOCA-salt on angiotensin dependency and surgical reversal of hypertension in two-kidney, one clip renal hypertensive rats.
    Takata Y; Doyle AE
    J Hypertens; 1983 Jun; 1(1):57-63. PubMed ID: 6397514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of captopril on the renal hemodynamics during aprotinin infusion in anesthetized dogs.
    Mizumura Y; Matsumoto M; Nishino A; Takata M; Iida H; Sugimoto T
    Ren Physiol; 1984; 7(5):299-303. PubMed ID: 6207570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacin.
    Miyamori I; Brown MJ; Dollery CT
    Clin Exp Hypertens (1978); 1980; 2(6):935-45. PubMed ID: 7004806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of the blood pressure and renal hemodynamic effects of captopril.
    Hall JE; Granger JP
    Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients.
    Millar JA; McGrath BP; Matthews PG; Johnston CI
    Clin Sci (Lond); 1981 Jul; 61(1):75-83. PubMed ID: 7018813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal vasodilatation caused by captopril in conscious normotensive and Goldblatt hypertensive dogs.
    Zimmerman BG; Mommsen C; Kraft E
    Proc Soc Exp Biol Med; 1980 Sep; 164(4):459-65. PubMed ID: 6997885
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
    Chen K; Zhang X; Dunham EW; Zimmerman BG
    Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alpha 1-adrenoceptor blockade on blood pressure and iliac vascular resistance in normotensive and Goldblatt hypertensive dogs; influence of dietary salt and DOCA-salt.
    Zeigler DW; Zimmerman BG
    J Hypertens; 1987 Aug; 5(4):407-12. PubMed ID: 2889779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of captopril-induced renal vasodilatation in anesthetized dogs after nonhypotensive hemorrhage.
    Wong PC; Zimmerman BG
    J Pharmacol Exp Ther; 1980 Oct; 215(1):104-9. PubMed ID: 7005423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma renin activity and hypotensive effect of captopril in dogs.
    Hamed AT; Lokhandwala MF; Buckley JP; Jandhyala BS
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):195-204. PubMed ID: 6994184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.